Nerhadou International for Pharmaceuticals and Nutraceuticals, commonly referred to as Nerhadou, is a leading player in the pharmaceutical and nutraceutical sectors, headquartered in Egypt (EG). Established in 1999, the company has made significant strides in developing high-quality products that cater to both local and international markets, with a strong presence across the Middle East and North Africa. Nerhadou's core offerings include a diverse range of pharmaceuticals and nutraceuticals, distinguished by their commitment to innovation and quality. The company is renowned for its advanced manufacturing processes and adherence to international standards, ensuring the efficacy and safety of its products. With a robust market position, Nerhadou has achieved notable milestones, including numerous certifications and partnerships that underscore its reputation as a trusted provider in the industry.
How does Nerhadou International for Pharmaceuticals and Nutraceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nerhadou International for Pharmaceuticals and Nutraceuticals's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nerhadou International for Pharmaceuticals and Nutraceuticals, headquartered in Egypt (EG), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, it is unclear what specific initiatives or commitments the company has in place regarding carbon emissions reduction or climate action. Without available data or commitments, it is challenging to assess their environmental impact or sustainability efforts within the pharmaceuticals and nutraceuticals industry. In the absence of emissions data and reduction initiatives, Nerhadou International's climate strategy remains unspecified, highlighting a potential area for future development in corporate sustainability practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nerhadou International for Pharmaceuticals and Nutraceuticals has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.